![]() ![]() | Turtoi, A., Mottet, D., Matheus, N., Dumont, B., Peixoto, P., Hennequière, V., Deroanne, C., Colige, A., De Pauw, E., Bellahcene, A., & Castronovo, V. (2024). Correction: The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells. Angiogenesis, 27 (1), 121 - 122. doi:10.1007/s10456-023-09898-1 ![]() |
![]() ![]() | Giacomini, A., Turati, M., Grillo, E., Rezzola, S., Ghedini, G. C., Schuind, A. C., Foglio, E., Maccarinelli, F., Faletti, J., Filiberti, S., Chambery, A., Valletta, M., Melocchi, L., Gofflot, S., Chiavarina, B., Turtoi, A., Presta, M., & Ronca, R. (2023). The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer. Experimental Hematology and Oncology, 12 (1), 82. doi:10.1186/s40164-023-00441-y ![]() |
![]() ![]() | Chiavarina, B., Costanza, B., Ronca, R., Blomme, A., Rezzola, S., Chiodelli, P., Giguelay, A., Belthier, G., Doumont, G., Van Simaeys, G., Lacroix, S., Yokobori, T., Erkhem-Ochir, B., Balaguer, P., Cavailles, V., Fabbrizio, E., Di Valentin, E., Gofflot, S., Detry, O., ... Turtoi, A. (January 2021). Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis. Theranostics, 11 (4), 1626-1640. doi:10.7150/thno.51507 ![]() |
![]() ![]() | Costanza, B., Rademaker, G., Turtoi, A., Bellahcene, A., Castronovo, V., & Peulen, O. (October 2019). TGFBI, an ECM interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration [Poster presentation]. Pancreatic Cancer Symposium 2019, Toulouse, France. |
![]() ![]() | Peulen, O., Rademaker, G., Anania, S., Turtoi, A., Bellahcene, A., & Castronovo, V. (August 2019). Ferlin overview: from membrane to cancer biology. Cells, 8, 954. doi:10.3390/cells8090954 ![]() |
![]() ![]() | Costanza, B., Rademaker, G., Tiamiou, A., De Tullio, P., Leenders, J., Blomme, A., Bellier, J., Bianchi, E., Turtoi, A., Delvenne, P., Bellahcene, A., Peulen, O.* , & Castronovo, V.*. (2019). TGFBI, an ECM interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration. International Journal of Cancer. doi:10.1002/ijc.32247 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Nokin, M.-J., Bellier, J., Durieux, F., Peulen, O., Rademaker, G., Gabriel, M., Monseur, C., CHARLOTEAUX, B., Verbeke, L., van Laere, S., RONCARATI, P., Herfs, M., Lambert, C., Scheijen, J., Schalkwijk, C., Colige, A., Caers, J., Delvenne, P., Turtoi, A., ... Bellahcene, A. (2019). Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer. Breast Cancer Research, 21(1, 11. doi:10.1186/s13058-018-1095-7 ![]() |
![]() ![]() | Blomme, A., van Simaeys, G., Doumont, G., Costanza, B., Bellier, J., Otaka, Y., Sherer, F., LOVINFOSSE, P., Boutry, S., Palacios, A. P., De Pauw, E., Hirano, T., Yokobori, T., Hustinx, R., Bellahcene, A., Delvenne, P., DETRY, O., Goldman, S., Nishiyama, M., ... Turtoi, A. (March 2018). Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases. Oncogene, 37 (9), 1237-1250. doi:10.1038/s41388-017-0018-x ![]() |
![]() ![]() | Costanza, B., Turtoi, A., Bellahcene, A., Hirano, T., Peulen, O., Blomme, A., Hennequiere, J., MUTIJIMA NZARAMBA, E., Boniver, J., Meuwis, M.-A., JOSSE, C., KOOPMANSCH, B., SEGERS, K., Yokobori, T., Fahmy, K., Thiry, M., COIMBRA MARQUES, C., Garbacki, N., Colige, A., ... Castronovo, V. (2018). Innovative methodology for the identification of soluble biomarkers in fresh tissues. Oncotarget, 9 (12), 10665-10680. doi:10.18632/oncotarget.24366 ![]() |
![]() ![]() | Costanza, B., Umelo, I., Bellier, J., Turtoi, A., & Castronovo, V. (2017). Stromal Modulators of TGF-β in Cancer. Journal of Clinical Medicine. doi:10.3390/jcm6010007 ![]() |
![]() ![]() | Chiavarina, B., Nokin, M.-J., Bellier, J., Durieux, F., BLETARD, N., Sherer, F., LOVINFOSSE, P., Peulen, O., Verset, L., Dehon, R., Demetter, P., Turtoi, A., Uchida, K., Goldman, S., Hustinx, R., Delvenne, P., Castronovo, V., & Bellahcene, A. (2017). Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer. International Journal of Molecular Sciences, 18 (1). doi:10.3390/ijms18010213 ![]() |
![]() ![]() | Blomme, A., Fahmy, K., Peulen, O., Costanza, B., Fontaine, M., Struman, I., Baiwir, D., De Pauw, E., Thiry, M., Bellahcene, A., Castronovo, V.* , & Turtoi, A.*. (2016). Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes. Oncotarget. doi:10.18632/oncotarget.13276 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Blomme, A., Costanza, B., De Tullio, P., Thiry, M., Van Simaeys, G., Boutry, S., Doumont, G., Di Valentin, E., Hirano, T., Yokobori, T., GOFFLOT, S., Peulen, O., Bellahcene, A., Sherer, F., Le Goff, C., Cavalier, E., Mouithys-Mickalad, A., Jouret, F., CUSUMANO, G., ... Turtoi, A. (2016). Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer. Oncogene. doi:10.1038/onc.2016.369 ![]() |
![]() ![]() | Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Scheijen, J., Schalkwijk, C., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., ... Bellahcene, A. (2016). Methylglyoxal, a glycolysis side-product, induces Hsp90 glycation and YAP- mediated tumor growth and metastasis. eLife. doi:10.7554/eLife.19375 ![]() |
![]() ![]() | Henry, A., Nokin, M.-J., Leroi, N., Lallemand, F., Lambert, J., Goffart, N., RONCARATI, P., BIANCHI, E., Peixoto, P., Blomme, A., Turtoi, A., Peulen, O., Habraken, Y., Scholtes, F., Martinive, P., Delvenne, P., Rogister, B., Castronovo, V., & Bellahcene, A. (2016). New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity. Oncotarget. doi:10.18632/oncotarget.11483 ![]() |
![]() ![]() | Henry, A., Nokin, M.-J., Leroi, N., LALLEMAND, F., Lambert, J., Goffart, N., Peixoto, P., Blomme, A., BIANCHI, E., Habraken, Y., RONCARATI, P., Peulen, O., SCHOLTES, F., MARTINIVE, P., Rogister, B., Delvenne, P., Turtoi, A., Castronovo, V., & Bellahcene, A. (22 March 2016). Osteopontin predicts radiotherapy response of glioblastoma patients : new role in DNA damage repair [Paper presentation]. 3rd Symposium on small animal precision image-guided radiotherapy, Gand, Belgium. |
![]() ![]() | Turtoi, A., Otaka, Y., Rokudai, S., Yokobori, T., Costanza, B., Oyama, T., Kuwano, H., DELWAIDE, J., DELVENNE, P., DETRY, O., Castronovo, V., & Nishiyama, M. (March 2016). Discovery of novel accessible proteins for therapeutic targeting of hepatocellular carcinoma. Acta Gastro-Enterologica Belgica, 79 (1), 13. ![]() |
![]() ![]() | Blomme, A., Cusumano, P., Peulen, O., Bellahcene, A., Castronovo, V., & Turtoi, A. (2016). L'asporine : une nouvelle defense naturelle contre le cancer du sein. MS. Medecine Sciences, 32 (11), 1019-1022. doi:10.1051/medsci/20163211020 ![]() |
![]() ![]() | Fahmy, K., Gonzalez, A., Arafa, M., Peixoto, P., Bellahcene, A., Turtoi, A., Delvenne, P., Thiry, M., Castronovo, V., & Peulen, O. (2016). Myoferlin plays a key role in VEGFA secretion and impacts tumor-associated angiogenesis in human pancreas cancer. International Journal of Cancer, 138, 652-663. doi:10.1002/ijc.29820 ![]() |
![]() ![]() | Costanza, B., Blomme, A., Bellahcene, A., Peulen, O., MUTIJIMA NZARAMBA, E., DELVENNE, P., De Pauw, E., DETRY, O., COIMBRA MARQUES, C., Castronovo, V., & Turtoi, A. (2016). EXPEL: A Novel Non-Destructive Method for Mining Soluble Tumor Biomarkers. Acta Gastro-Enterologica Belgica, 79 (1), 11. ![]() |
![]() ![]() | Peixoto, P.* , Blomme, A.* , Costanza, B.* , Ronca, R., Rezzola, S., Palacios, A., SCHOYSMAN, L., Boutry, S., Goffart, N., Peulen, O., Maris, P., Di Valentin, E., Hennequière, V., BIANCHI, E., Henry, A., Meunier, P., Rogister, B., MULLER, R., Delvenne, P., ... Turtoi, A. (2016). HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies. Oncogene. doi:10.1038/onc.2015.506 ![]() * These authors have contributed equally to this work. |
Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Turtoi, A., Costanza, B., Smargiasso, N., Baiwir, D., Leenders, J., De Tullio, P., BIANCHI, E., Thiry, M., Uchida, K., Spiegel, D., Cochrane, J., Hutton, C., De Pauw, E., ... Bellahcene, A. (29 September 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Poster presentation]. Cancer and Metabolism Conference, Cambridge, United Kingdom. |
![]() ![]() | Henry, A., Bellahcene, A., Castronovo, V., Peixoto, P., Goffart, N., Lallemand, F., Leroi, N., Peulen, O., MARTINIVE, P., Habraken, Y., Turtoi, A., Rogister, B., & Blomme, A. (Other coll.). (10 September 2015). Osteopontin as a new target in glioblastoma progression and resistance to radiotherapy [Paper presentation]. II International Symposium on clinical and basic investigation in glioblastoma, Toledo, Spain. |
Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Peulen, O., Blomme, A., Smargiasso, N., De Tullio, P., BIANCHI, E., Baiwir, D., Thiry, M., Turtoi, A., De Pauw, E., DELVENNE, P., Castronovo, V., & Bellahcene, A. (09 September 2015). Methylglyoxal, a glycolysis side-product, induces Hsp90 post-translational glycation and YAP-mediated breast tumor growth and metastasis [Poster presentation]. Metabolism in Cancer and Stromal Cells, Leuven, Belgium. |
![]() ![]() | Costanza, B., Blomme, A., MUTIJIMA NZARAMBA, E., DELVENNE, P., DETRY, O., Castronovo, V., & Turtoi, A. (March 2015). Expel: a novel non-destructive method for mining soluble tumor biomarkers. Acta Gastro-Enterologica Belgica, 78 (1), 13. ![]() |
![]() ![]() | Perez Palacios, A., Blomme, A., Boutry, S., Doumont, G., Sherer, F., Van Simaeys, G., Debois, D., JERUSALEM, G., COLLIGNON, J., DELVENNE, P., DETRY, O., De Pauw, E., Muller, R., Goldman, S., Castronovo, V., & Turtoi, A. (March 2015). Metabolomic, proteomic and preclinical imaging of patient-derived tumor xenografts for improving treatment of liver metastases patients. Acta Gastro-Enterologica Belgica, 78 (1), 134. ![]() |
![]() ![]() | Blomme, A., Costanza, B., Thiry, M., De Tullio, P., Perez-Palacios, A., Mouithys-Mickalad, A., LIFRANGE, E., Delvenne, P., Castronovo, V., & Turtoi, A. (31 January 2015). Myoferlin Regulates Endosomal Trafficking and Tunes Cancer Cell Metabolism [Poster presentation]. ASSOCIATION BELGE POUR L'ETUDE DU CANCER "A.B.E.C» ANNUAL MEETING 2015: TUMOR METABOLISM AND MITOCHONDRIA, Louvain, Belgium. |
![]() ![]() | Fahmy, K., Peulen, O., Castronovo, V., Bellahcene, A., Turtoi, A., Thiry, M., Delvenne, P., PEIXOTO, P., Gonzalez, A., & ARAFA, M. (31 January 2015). Myoferlin: an indispensable component in VEGFA secretion by pancreas cancer cells [Poster presentation]. ASSOCIATION BELGE POUR L'ETUDE DU CANCER, Bruxelles, Belgium. |
![]() ![]() | Nokin, M.-J., Durieux, F., Peixoto, P., Chiavarina, B., Smargiasso, N., Baiwir, D., De Pauw, E., De Tullio, P., Thiry, M., Peulen, O., Turtoi, A., Castronovo, V., & Bellahcene, A. (27 January 2015). Accumulation of methylglyoxal, a glycolysis by-product modulates YAP1 transcription co-factor localization and activity in human breast cancer cells through HSP90 modification [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium. |
![]() ![]() | Blomme, A., Costanza, B., Thiry, M., De Tullio, P., Perez Palacios, A., LIFRANGE, E., DELVENNE, P., Castronovo, V., & Turtoi, A. (27 January 2015). Myoferlin regulates endosomal trafficking and tunes cancer cell metabolism [Poster presentation]. GIGA-DAY 2015: Current advances in medical genetics and genomics, Liège, Belgium. |
![]() ![]() | Fahmy, K., Gonzalez, A., Arafad, M., Turtoi, A., Bellahcene, A., DELVENNE, P., Thiry, M., Castronovo, V., & Peulen, O. (27 January 2015). Myoferlin: an indispensable component in VEGR-A secretion by pancreatic cancer cell [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium. |
![]() ![]() | Lamour, V., Henry, A., Kroonen, J., Nokin, M.-J., von Marschall, Z., Fisher, L., Chau, T.-L., Chariot, A., Sanson, M., Delattre, J.-Y., Turtoi, A., Peulen, O., Rogister, B., Castronovo, V., & Bellahcene, A. (2015). Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo. International Journal of Cancer. doi:10.1002/ijc.29454 ![]() |
![]() ![]() | Maris, P., Blomme, A., Palacios, A. P., Costanza, B., Bellahcene, A., BIANCHI, E., GOFFLOT, S., Drion, P., Trombino, G. E., Di Valentin, E., CUSUMANO, G., MAWEJA, S., JERUSALEM, G., Delvenne, P., LIFRANGE, E., Castronovo, V., & Turtoi, A. (2015). Asporin Is a Fibroblast-Derived TGF-beta1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer. PLoS Medicine, 12 (9), 1001871. doi:10.1371/journal.pmed.1001871 ![]() |
![]() ![]() | Turtoi, A., Blomme, A., & Castronovo, V. (2015). Intratumoral heterogeneity and consequences for targeted therapies. Bulletin du Cancer, 102 (1), 17-23. doi:10.1016/j.bulcan.2014.12.006 ![]() |
![]() ![]() | Turtoi, A., Peixoto, P., Castronovo, V., & Bellahcene, A. (2015). Histone deacetylases and cancer-associated angiogenesis: current understanding of the biology and clinical perspectives. Critical Reviews in Oncogenesis, 20 (1-2), 119-37. doi:10.1615/CritRevOncog.2014012423 ![]() |
![]() ![]() | Chiavarina, B.* , Nokin, M.-J.* , Durieux, F., BIANCHI, E., Turtoi, A., Peulen, O., Peixoto, P., Irigaray, P., Uchida, K., Belpomme, D., Delvenne, P., Castronovo, V., & Bellahcene, A. (2014). Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes. Oncotarget. doi:10.18632/oncotarget.2121 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Castronovo, V., Blomme, A., Delvenne, P., DETRY, O., & Turtoi, A. (March 2014). TGF-B induced protein IG-H3 is essential for the growth of human liver metastases. Acta Gastro-Enterologica Belgica, 77 (1), 05. ![]() |
![]() ![]() | Turtoi, A., Blomme, A., Debois, D., SOMJA, J., Delvaux, D., Patsos, G., Di Valentin, E., Peulen, O., MUTIJIMA NZARAMBA, E., De Pauw, E., Delvenne, P., DETRY, O., & Castronovo, V. (March 2014). Organized Proteomic Heterogeneity in Colorectal Cancer Liver Metastases and Implications for Therapies. Hepatology, 59 (3), 924-934. doi:10.1002/hep.26608 ![]() |
![]() ![]() | Turtoi, A., Blomme, A., Debois, D., SOMJA, J., De Pauw, E., DETRY, O., & Castronovo, V. (March 2014). Organized proteomic heterogeneity in colorectal liver metastases and implications for therapies. Acta Gastro-Enterologica Belgica, 77 (1), 07. ![]() |
![]() ![]() | Costanza, B., Blomme, A., Bellahcene, A., Hennequière, V., LIFRANGE, E., DELVENNE, P., Castronovo, V., & Turtoi, A. (2014). Myoferlin is a Key Regulator of HER Receptor Family Function in Breast Cancer [Paper presentation]. EDT Annual Mini symposium 2014. |
![]() ![]() | Turtoi, A.* , Blomme, A.* , BIANCHI, E., Maris, P., Vannozzi, R., Naccarato, A. G., DELVENNE, P., De Pauw, E., Bevilacqua, G., & Castronovo, V. (2014). Accessibilome of human glioblastoma: collagen-VI-alpha-1 is a new target and a marker of poor outcome. Journal of Proteome Research, 13 (12), 5660-5669. doi:10.1021/pr500657w ![]() * These authors have contributed equally to this work. |
![]() ![]() | Peulen, O.* , Gonzalez, A.* , Peixoto, P., Turtoi, A., Mottet, D., Delvenne, P., & Castronovo, V. (11 September 2013). The Anti-Tumor Effect of HDAC Inhibition in a Human Pancreas Cancer Model Is Significantly Improved by the Simultaneous Inhibition of Cyclooxygenase 2. PLoS ONE, 8 (9), 75102. doi:10.1371/journal.pone.0075102 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Warnock, G., Turtoi, A., Blomme, A., Bretin, F., Bahri, M. A., Lemaire, C., Libert, L., Seret, A., Luxen, A., Castronovo, V., & Plenevaux, A. (22 August 2013). In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: A new tool for oncology and radiotracer development. Journal of Nuclear Medicine, 54 (10), 1782-1788. doi:10.2967/jnumed.112.117150 ![]() |
Gonzalez, A., Peixoto, P., Turtoi, A., Mottet, D., Delvenne, P., Castronovo, V., & Peulen, O. (11 July 2013). Concomitant inhibition of class I HDAC and COX-2 exerts a antitumor effect in a human pancreatic cancer model [Poster presentation]. WIN2013 Symposium: "Personalized Cancer Therapy: from innovation to implemantation". |
![]() ![]() | Turtoi, A.* , Blomme, A.* , Bellahcene, A., Gilles, C., Hennequière, V., Peixoto, P., BIANCHI, E., Noël, A., De Pauw, E., LIFRANGE, E., Delvenne, P., & Castronovo, V. (2013). Myoferlin is a key regulator of EGFR activity in breast cancer. Cancer Research, 73, 5438-5448. doi:10.1158/0008-5472.CAN-13-1142 ![]() * These authors have contributed equally to this work. |
![]() ![]() | Calligaris, D., Longuespée, R., Debois, D., Asakawa, D., Turtoi, A., Castronovo, V., Noël, A., Bertrand, V., De Pauw-Gillet, M.-C., & De Pauw, E. (2013). Selected Protein Monitoring in Histological Sections by Targeted MALDI-FTICR in-source decay Imaging. Analytical Chemistry, 85 (4), 2117-26. doi:10.1021/ac302746t ![]() |
![]() ![]() | Fradet, A., Sorel, H., Depalle, B., Serre, C. M., Farlay, D., Turtoi, A., Bellahcene, A., Follet, H., Castronovo, V., Clezardin, P., & Bonnelye, E. (2013). A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancer. PLoS ONE, 8 (9), 75092. doi:10.1371/journal.pone.0075092 ![]() |
![]() ![]() | Dobson, R., Collodoro, M., Gilles, N., Turtoi, A., De Pauw, E., & Quinton, L. (December 2012). Secretion and maturation of conotoxins in the venom ducts of Conus textile. Toxicon, 60 (8), 1370-1379. doi:10.1016/j.toxicon.2012.09.013 ![]() |
![]() ![]() | Warnock, G., Turtoi, A., Blomme, A., Gonzalez, A., Bretin, F., Bahri, M. A., Lemaire, C., Seret, A., Castronovo, V., Luxen, A., & Plenevaux, A. (October 2012). In Ovo PET Imaging Of A Human Colorectal Carcinoma Model In Chicken Chorioallantoic Membrane [Poster presentation]. Annual Congress of the European Association of Nuclear Imaging, Milan, Italy. |
Blomme, A., Turtoi, A., & Castronovo, V. (September 2012). Imaging Guided Proteomics Unveils Heterogeneity in Colorectal Carcinoma Liver Metastases – Implications for Targeted Therapies [Paper presentation]. HUPO Meeting 2012, Boston, United States. |
Castronovo, V., & Turtoi, A. (21 June 2012). Biomarkers, uses of biomarkers and a method of identifying biomarkers. |
Castronovo, V., & Turtoi, A. (21 June 2012). Biomarkers, uses of biomarkers and a method of identifying biomarkers for colorectal carcinoma (CRC) liver metastasis. |
![]() ![]() | Calligaris, D., Debois, D., Turtoi, A., Castronovo, V., Noël, A., & De Pauw, E. (23 May 2012). A Promising Perspective for Pathologies Diagnosis by MALDI In-Source Decay Imaging with a FTMS System [Poster presentation]. 60th ASMS Conference on Mass Spectrometry, Vancouver, Canada. |
![]() ![]() | Blomme, A., Turtoi, A., Delvaux, D., Patsos, G., Somja, J., Debois, D., Delvenne, P., Warnock, G., Plenevaux, A., Luxen, A., Drion, P., DETRY, O., De Pauw, E., & Castronovo, V. (2012). Imaging Guided Proteomics Unveils Heterogeniety in Colorectal Carcinoma Liver Metastases – Implications for Targeted Therapies. In Proceedings Giga Day 2012. |
![]() ![]() | Turtoi, A., Blomme, A., Delvaux, D., Dumont, B., SOMJA, J., Debois, D., DELVENNE, P., De Pauw, E., DE ROOVER, A., Honoré, P., DETRY, O., & Castronovo, V. (May 2012). INTRA-TUMORAL HETEROGENEITY AND RATIONAL SELECTION OF ANTIGENS FOR TARGETED THERAPY OF LIVER METASTASES. Acta Chirurgica Belgica, 112 (3), 89.FP53. ![]() |
Turtoi, A., Blomme, A., & Castronovo, V. (24 April 2012). Rational selection of antigens for targeted therapy of liver metastases [Paper presentation]. Experimental Biology 2012, SAN DIEGO, United States. |
Castronovo, V., Matheus, N., Dumont, B., Peixoto, P., Hennequière, V., Deroanne, C., Colige, A., De Pauw, E., Bellahcene, A., Mottet, D., & Turtoi, A. (21 April 2012). The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells [Paper presentation]. Experimental Biology 2012, SAN DIEGO, United States. |
![]() ![]() | Dumont, B., Castronovo, V., Peulen, O., BLETARD, N., Clézardin, P., Delvenne, P., De Pauw, E., Turtoi, A., & Bellahcene, A. (2012). Differential proteomic analysis of a human breast tumor and its matched bone metastasis identifies cell membrane and extracellular proteins associated with bone metastasis. Journal of Proteome Research. doi:10.1021/pr201022n ![]() |
![]() ![]() | Turtoi, A., Musmeci, D., Naccarato, A. G., Scatena, C., Ortenzi, V., Kiss, R., Murtas, D., Patsos, G., Mazzucchelli, G., De Pauw, E., Bevilacqua, G., & Castronovo, V. (2012). Sparc-like protein 1 is a new marker of human glioma progression. Journal of Proteome Research, 11 (10), 5011-21. doi:10.1021/pr3005698 ![]() |
![]() ![]() | Turtoi, A., & Castronovo, V. (2012). Isotopically labeled proteome as an internal standard for multiple reaction monitoring-based biomarker quantification. Expert Review of Proteomics, 9 (3), 245-8. doi:10.1586/epr.12.27 ![]() |
![]() ![]() | Turtoi, A., Mottet, D., Matheus, N., Dumont, B., Peixoto, P., Hennequière, V., Deroanne, C., Colige, A., De Pauw, E., Bellahcene, A., & Castronovo, V. (2012). The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells. Angiogenesis. doi:10.1007/s10456-012-9279-8 ![]() |
![]() ![]() | Turtoi, A., Musmeci, D., Wang, Y., Dumont, B., Somja, J., Bevilacqua, G., De Pauw, E., Delvenne, P., & Castronovo, V. (02 September 2011). Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma. Journal of Proteome Research, 10 (9), 4302-13. doi:10.1021/pr200527z ![]() |
![]() ![]() | Turtoi, A., Dumont, B., Greffe, Y., Blomme, A., Mazzucchelli, G., Delvenne, P., MUTIJIMA NZARAMBA, E., LIFRANGE, E., De Pauw, E., & Castronovo, V. (01 July 2011). Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues. Journal of Proteome Research, 10 (7), 3160-82. doi:10.1021/pr200212r ![]() |
![]() ![]() | Castronovo, V., Blomme, A., Dumont, B., & Turtoi, A. (2011). Development of Targeted Therapies for Liver Metastases: Is Heterogeneity a Major Issue? [Paper presentation]. Annual Meeting at Experimental Biology, Washington DC, United States. ![]() |
![]() ![]() | Turtoi, A., De Pauw, E., & Castronovo, V. (January 2011). Innovative Proteomics for the Discovery of Systemically Accessible Cancer Biomarkers Suitable for Imaging and Targeted Therapies. American Journal of Pathology, 178 (1), 12-18. doi:10.1016/j.ajpath.2010.08.004 ![]() |
![]() ![]() | Turtoi, A., Sharan, R., Srivastava, A., & Schneeweiss, F. (October 2010). Proteomic and genomic modulations induced by gamma-irradiation of human blood lymphocytes. International Journal of Radiation Biology, 86 (10), 888-904. doi:10.3109/09553002.2010.486016 ![]() |
![]() ![]() | Fleron, M., Greffe, Y., Musmeci, D., Massart, A.-C., Hennequière, V., Mazzucchelli, G., Waltregny, D., De Pauw-Gillet, M.-C., De Pauw, E., Castronovo, V., & Turtoi, A. (10 September 2010). Novel post-digest isotope coded protein labeling method for phospho- and glycoproteome analysis. Journal of Proteomics, 73 (10), 1986-2005. doi:10.1016/j.jprot.2010.06.003 ![]() |
![]() ![]() | Turtoi, A., Brown, I., Schläger, M., & Schneeweiss, F. H. (August 2010). Gene expression profile of human lymphocytes exposed to (211)At alpha particles. Radiation Research, 174, 125-136. doi:10.1667/RR1659.1 ![]() |
![]() ![]() | Eppe, G., Turtoi, A., & De Pauw, E. (June 2010). Metabolomic Profile of Human Serum to Determine the Age Related Immunosenescence [Poster presentation]. 58th American Society for Mass Spectrometry. |
![]() ![]() | Fleron, M., Greffe, Y., Massart, A.-C., Hennequière, V., Musmeci, D., Mazzucchelli, G., De Pauw-Gillet, M.-C., Castronovo, V., De Pauw, E., & Turtoi, A. (16 April 2010). Novel Relative ICPL Based Quantitative Phospho- and Glycoproteome Analysis Method [Poster presentation]. Belgian Society for Mass Spectrometry : Annual Meeting 2010, Leuven, Belgium. |
![]() ![]() | Kischel, P., Waltregny, D., Dumont, B., Turtoi, A., Greffe, Y., Kirsch, S., De Pauw, E., & Castronovo, V. (2010). Versican overexpression in human breast cancer lesions: Known and new isoforms for stromal tumor targeting. International Journal of Cancer, 126 (3), 640-50. doi:10.1002/ijc.24812 ![]() |
![]() ![]() | Turtoi, A., Mazzucchelli, G., & De Pauw, E. (2010). Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach. Talanta, 80 (4), 1487-95. doi:10.1016/j.talanta.2009.07.035 ![]() |
![]() ![]() | Castronovo, V., Wang, Y. H., Musmeci, D., Dumont, B., & Turtoi, A. (2010). Proteomic analysis of human pancreas cancers for the identification of targetable biomarkers [Paper presentation]. Federation of American Societies for Experimental Biology, Steamboat Springs, Colorado, United States. ![]() |
![]() ![]() | Dobson, R., Corbesier, C., Collodoro, M., Gilles, N., Turtoi, A., Kirsch, S., De Pauw, E., & Quinton, L. (02 December 2009). Secretion and maturation of toxins in the venom duct of Conustextile [Paper presentation]. 16ème Rencontres de la Société Francaise d'Etude des Toxines, Paris, France. |
![]() ![]() | Castronovo, V., Waltregny, D., Detry, O., Coimbra Marques, C., De Roover, A., Honore, P., De Pauw, E., & Turtoi, A. (October 2009). Le ciblage therapeutique: vers une guerre propre et efficace contre le cancer [Paper presentation]. Journée Synthèse 2009 CHU La recherche translationnelle au CHU de Liège, Liège, Belgium. |
![]() ![]() | Turtoi, A., Mazzucchelli, G., Dobson, R., & De Pauw, E. (01 June 2009). Relative serum protein quantification based upon ICPL and 2D-LC-MS identifies potential frailty biomarkers in elderly patients [Poster presentation]. 57th American Society for Mass Spectrometry (ASMS) Conference, Philadelphia, Pennsylvania, United States. |
![]() ![]() | Castronovo, V., Waltregny, D., Detry, O., Coimbra Marques, C., De Roover, A., Honore, P., De Pauw, E., & Turtoi, A. (2009). Le ciblage thérapeutique : vers une guerre propre et efficace contre le cancer. Revue Médicale de Liège, 64, 20-23. ![]() |
![]() ![]() | Turtoi, A., & Schneeweiss, F. H. A. (2009). Effect of 211At alpha-particle irradiation on expression of selected radiation responsive genes in human lymphocytes. International Journal of Radiation Biology, 85 (5), 403-12. doi:10.1080/09553000902838541 ![]() |
![]() ![]() | Turtoi, A. (November 2008). Application of Protein Mass Spectrometry Analysis in Biomarker Discovery and Systems Biology [Paper presentation]. Pathway Analysis in Proteomics-I, Oeiras, Portugal. |
![]() ![]() | Turtoi, A., Brown, I., Oskamp, D., & Schneeweiss, F. H. A. (2008). Early gene expression in human lymphocytes after gamma-irradiation-a genetic pattern with potential for biodosimetry. International Journal of Radiation Biology, 84 (5), 375-87. doi:10.1080/09553000802029886 ![]() |
![]() ![]() | Turtoi, A. (2008). Untersuchung frühzeitiger Reaktionen lymphozytärer Proteine auf γ-Bestrahlung humanen Vollbluts und deren Dosisabhängigkeit – Voraussetzung für die Entwicklung eines individuellen strahlenbiologischen Dosimeters. Jülich, Germany: Forschungszentrum Jülich. |
![]() ![]() | Turtoi, A., Srivastava, A., Sharan, R., Oskamp, D., Hille, R., & Schneeweiss, F. (2007). Early response of lymphocyte proteins after gamma-radiation. Journal of Radioanalytical and Nuclear Chemistry, 274 (2), 435-39. doi:10.1007/s10967-007-1133-x ![]() |